Remove 08 11 right-to-health-patient-rights
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – January

SQA

Relevant matters are hereby announced as follows: As of 01 December 2022, the Electronic Certificates of Documentation for Export of APIs to the EU and Certificate of a Pharmaceutical Product will be put into use. Efforts should be made to promote and guide the use of electronic certificates.

article thumbnail

KLAS Differentiates Patient Communications from Patient-Driven Care Management Solutions

Healthcare IT Today

In a recent report, KLAS Research separated their Patient Outreach category into two new categories. The Patient Communications category groups together solutions that are primarily focused on administrative outcomes like appointment reminders and payment reminders. Why the separation? Administrative communication.

Doctors 80
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – March And April

SQA

As recommended by the International Health Regulations (IHR), there must be a vector-free zone at seaports, airports, and land crossing and within a perimeter of 400 meters around these entry points. For this, it is necessary to maintain regular active surveillance and vector control so that the risk of disease transmission is reduced.

FDA 40
article thumbnail

SQA Regulatory Surveillance Summary | Monthly Update 2023 – July and August 2023

SQA

ANVISA Prohibits Cosmetics Used Irregularly as Injectables, 08 August 2023 ANVISA determined the precautionary interdiction of all batches of Cosmobeauty Dermo Biostimulator and Filler and Cosmobeauty Tonifying Ultraconcentrated Fluid, manufactured by the company Bio Essencialli Indústria e Comércio de Cosméticos.

FDA 40
article thumbnail

The FDA and Feasible Alternative Designs

Drug & Device Law

Striking the right balance between safety and efficacy is especially difficult with respect to vaccines, which affect public as well as individual health. Striking the right balance between safety and efficacy is especially difficult with respect to vaccines, which affect public as well as individual health. at 237-38.

FDA 59